Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes
Cátia V. Vaz, Ricardo Marques, Marco G. Alves, et al.
Journal of Cancer Research and Clinical Oncology (2015) Vol. 142, Iss. 1, pp. 5-16
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
Carly C. Barron, Philip J. Bilan, Theodoros Tsakiridis, et al.
Metabolism (2015) Vol. 65, Iss. 2, pp. 124-139
Closed Access | Times Cited: 364
GLUT1 regulates cell glycolysis and proliferation in prostate cancer
Hengjun Xiao, Jun Wang, Weixin Yan, et al.
The Prostate (2017) Vol. 78, Iss. 2, pp. 86-94
Open Access | Times Cited: 144
Concise Review: Prostate Cancer Stem Cells: Current Understanding
Sergej Skvortsov, Ira Skvortsova, Dean G. Tang, et al.
Stem Cells (2018) Vol. 36, Iss. 10, pp. 1457-1474
Open Access | Times Cited: 118
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress
Pedro González‐Menéndez, David Hevia, Rebeca Alonso‐Arias, et al.
Redox Biology (2018) Vol. 17, pp. 112-127
Open Access | Times Cited: 76
The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Pedro González‐Menéndez, David Hevia, Juan C. Mayo, et al.
International Journal of Cancer (2017) Vol. 142, Iss. 12, pp. 2414-2424
Open Access | Times Cited: 73
Revisiting the Crabtree/Warburg effect in a dynamic perspective: a fitness advantage against sugar-induced cell death
Elisabetta de Alteriis, Fabrizio Cartenì, Palma Parascandola, et al.
Cell Cycle (2018) Vol. 17, Iss. 6, pp. 688-701
Open Access | Times Cited: 70
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
Niki M. Zacharias, Christopher McCullough, Sriram S. Shanmugavelandy, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 64
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors
Martin Bakht, Jessica M. Lovnicki, Janice Tubman, et al.
Journal of Nuclear Medicine (2019) Vol. 61, Iss. 6, pp. 904-910
Open Access | Times Cited: 62
GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers
Jun Wang, Wenhao Xu, Beihe Wang, et al.
Cancer Letters (2020) Vol. 485, pp. 45-55
Closed Access | Times Cited: 56
Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells
Kang Wang, Yan Lu, Haibin Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer
Zhigang Liu, Wenhe Zhu, Xiangyu Kong, et al.
Oncology Reports (2019)
Open Access | Times Cited: 53
A MSN-based tumor-targeted nanoplatform to interfere with lactate metabolism to induce tumor cell acidosis for tumor suppression and anti-metastasis
Zhaoxia Chen, Miao‐Deng Liu, Deng‐Ke Guo, et al.
Nanoscale (2020) Vol. 12, Iss. 5, pp. 2966-2972
Closed Access | Times Cited: 44
GLUT1 expression in high-risk prostate cancer: correlation with 18F-FDG-PET/CT and clinical outcome
Salma Meziou, Cassandra Ringuette Goulet, Hélène Hovington, et al.
Prostate Cancer and Prostatic Diseases (2020) Vol. 23, Iss. 3, pp. 441-448
Closed Access | Times Cited: 42
Immune response of silver pomfret (Pampus argenteus) to Amyloodinium ocellatum infection
Youyi Zhang, Jiabao Hu, Yaya Li, et al.
Journal of Fish Diseases (2021) Vol. 44, Iss. 12, pp. 2111-2123
Closed Access | Times Cited: 35
The Evolving Role of 18F-FDG PET/CT in Diagnosis and Prognosis Prediction in Progressive Prostate Cancer
Kai Shen, Bo Liu, Xiang Zhou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 34
Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study
David Hevia, Pedro González‐Menéndez, Mario Fernández‐Fernández, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 8, pp. 1620-1620
Open Access | Times Cited: 46
LincRNA‐p21 suppresses development of human prostate cancer through inhibition of PKM2
Xiaohai Wang, Yongzhi Xu, Xingjie Wang, et al.
Cell Proliferation (2017) Vol. 50, Iss. 6
Open Access | Times Cited: 46
Sodium-glucose cotransporters: new targets of cancer therapy?
Ivana Vrhovac, Josip Madunić, Davorka Breljak, et al.
Archives of Industrial Hygiene and Toxicology (2018) Vol. 69, Iss. 4, pp. 278-285
Open Access | Times Cited: 42
Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect
Wenjing Xu, Jin Ding, Shida Kuang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II
Guoyu Yu, Chien-Jui Cheng, Song-Chang Lin, et al.
Cancer Research (2018) Vol. 78, Iss. 10, pp. 2490-2502
Open Access | Times Cited: 35
3-Bromopyruvate and sodium citrate induce apoptosis in human gastric cancer cell line MGC-803 by inhibiting glycolysis and promoting mitochondria-regulated apoptosis pathway
Xingyu Guo, Xiaodong Zhang, Tingan Wang, et al.
Biochemical and Biophysical Research Communications (2016) Vol. 475, Iss. 1, pp. 37-43
Open Access | Times Cited: 34
Prostate Cancer Energetics and Biosynthesis
Chenchu Lin, Travis C. Salzillo, David Bader, et al.
Advances in experimental medicine and biology (2019), pp. 185-237
Open Access | Times Cited: 32
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression
Joanna Łaźniewska, Ka Lok Li, I. R. Johnson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Revisiting prostate cancer metabolism: From metabolites to disease and therapy
Henrique J. Cardoso, Tiago M. A. Carvalho, Lara R. S. Fonseca, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1499-1538
Closed Access | Times Cited: 26
Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model
Nourridine Siewe, Avner Friedman
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262453-e0262453
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top